Precision medicine is here to stay and our task of understanding pharma/bio markets is becoming yet more complicated. This presentation, given by Simon Fitall at the recent PMRG CONNECT meeting, gives a brief primer on the Precision Medicine Initiative and goes on to describe how the new data that is coming from precision medicine opens opportunities for yet more improvement of our understanding of complex patients.